基托桑基纳米凝在现代药物交付中:专注于蛋白质和基因应用
Muhammet Davut Arpa1, Fatma Julide Akbuğa1
1Department of Pharmaceutical Technology, School of Pharmacy, Istanbul Medipol University, 34815 İstanbul, Türkiye.
Gels (Basel, Switzerland)
|September 26, 2025
概括
奇托纳米凝提供先进的药物输送与生物相容性和有针对性的运输. 这些天然聚合物系统对基因疗法,免疫疗法和有效传递生物药物的治疗有希望.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 纳米凝越来越多地因其生物相容性,受控释放和有针对性的传递能力而得到认可.
- 奇托是一种天然的多糖,由于其正电荷,生物降解性和功能多功能性,它是纳米凝配方的首选生物聚合物.
研究的目的:
- 综合审查基托基纳米凝的治疗应用.
- 强调它们在运输蛋白质/,抗原和基因方面的实用性.
- 评估生产方法,修饰策略,细胞运输机制和生物活动.
主要方法:
- 文献综述专注于基托基纳米凝.
- 分析生产技术和化学修饰方法.
- 细胞吸收和细胞内贩运机制的评估.
主要成果:
- 奇托桑纳米凝在基因疗法,免疫疗法和生物制剂的输送中显示出显著的潜力.
- 关键特征包括有效的细胞内向,增强的内体逃生和持续释放特征.
- 这些纳米载体促进了敏感生物分子的运输,如蛋白质,和抗原.
结论:
- 基因疗法和免疫疗法等多种治疗应用中,基因纳米凝具有很高的前景.
- 它们独特的特性支持有效的生物剂的传递,并为临床翻译提供了潜力.
- 需要进一步的研究,才能充分实现这些先进的纳米载体系统的临床潜力.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...


